Listed below is the senior management team at Regenexx and the Centeno-Schultz Clinic.
Christopher J. Centeno, M.D.
Christopher J. Centeno, M.D. is an international expert and specialist in regenerative medicine and the clinical use of mesenchymal stem cells in orthopedics. He is board certified in physical medicine and in pain management. Dr. Centeno is one of the few physicians in the world with extensive experience in the culture expansion of and clinical use of adult stem cells to treat orthopedic injuries. He and his partner John Schultz were the first physicians in the US to use culture expanded stem cells in patients through an IRB approved study that spanned 2005-2007. He is a founding member of the International Cellular Medicine Society. Dr. Centeno treats patients from all over the US who travel to Colorado to under-go innovative, non-surgical treatments. Dr. Centeno has chaired multiple international research based conferences. He also maintains an active research based practice, with multiple publications listed in the US National Library of Medicine. Dr. Centeno has also served as editor-in-chief of a medical research journal dedicated to traumatic injury.
Dr. Centeno trained at the Baylor College of Medicine, Texas Medical Center and the Institute for Rehabilitation Research. He hails from both Florida and New York and currently resides in Boulder, Colorado with his wife and three children.
Carl Measer, MBA
Mr. Measer brings more than 20 years of medical administration experience and strategic business planning. He presently serves as the Chief Operating Officer and member of the board of directors for Regenerative Sciences as well as Practice Administrator for the Centeno-Schultz Clinic. Previously, he directed ambulatory surgery centers, is licensed as a Skilled Nursing Home Administrator, and managed multi-location physician groups. Mr. Measer is responsible for all operations and personnel.
He received his BA in economics from The University of Connecticut and his MBA in Health Care Administration from The University of Phoenix.
Patrick Reischling, MBS
Patrick Reischling is currently the President of Regenerative Sciences, LLC. He brings more than 10 years of experience in medical device and biologics research and product development. Prior to joining Regenerative Sciences, he was the Director of Clinical Research for Zimmer Orthobiologics, managing clinical studies on tissue based and biologic products for articular cartilage and bone repair and working with senior management on product development and business development strategy. Prior to that, he worked in clinical outcomes research for Orthopedics and Spine companies. He has extensive knowledge biologic research, FDA regulations and product development. He received his BA in Biology and an MBS in Exercise Science from the University of Colorado at Colorado Springs.
John Schultz, MD
Dr. Schultz is widely experienced in percutaneous treatment of musculoskeletal disorders, including localized adult stem cell therapy. He plays a crucial role in training physicians to use the Regenexx® procedure. His wide experience with patients with musculoskeletal disorders allows him to play a significant role in physician outreach.
John earned his medical degree from George Washington University and he completed his residency in anesthesiology at the University of Utah. He further specialized during two fellowships in pain management and critical care medicine. He is double board certified in pain medicine and anesthesia.